BOSTON, May 31, 2023 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for ...
BOSTON, Jan. 30, 2024 (GLOBE NEWSWIRE) -- Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for ...
BOSTON--(BUSINESS WIRE)--Jnana Therapeutics, a clinical-stage biotechnology company leveraging its next-generation chemoproteomics platform to discover medicines for challenging-to-drug targets, will ...
Bill Baggs first met JNT as a fan at the BBC Dr Who Production Office in the 80's. He later worked with JNT on various projects. Bill conducted this interview as part of the BBV dvd '30 Years of Time ...
BOSTON--(BUSINESS WIRE)--Jnana Therapeutics, a biotechnology company utilizing its next generation chemoproteomic platform to address well-validated but hard-to-drug targets, today announced that it ...
JNT: Journal of Narrative Theory continues to follow the high standards set during its first four decades of publication; the newly focused JNT showcases theoretically sophisticated essays that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results